North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030
North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement…
These 4 anti-obesity drug stocks could soar, Berenberg says
The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers…
